Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

Miguel Gonzalez-Velez, MD

Articles by Miguel Gonzalez-Velez, MD

sebra - stock.adobe.com

How to approach immune checkpoint inhibitor therapy in prostate cancer

ByMiguel Gonzalez-Velez, MD,Alan H. Bryce, MD

August 18th 2020

Next-generation sequencing identifies subtypes that may benefit from immune checkpoint inhibitors.

Latest Updated Articles

Trending on Urology Times

GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance

Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC

Jim Hu, MD, discusses new posterior approach to nerve-sparing prostatectomy

Permanent J code for mitomycin for intravesical solution now in effect

The Expert APProach: Digital Health, AI, and the Evolving Role of APPs in Urology, with Jennifer Bepple, MD, MMCi